X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Monday: Moran finds Part B medicine prices are stable, not a key driver of Medicare costs

By Nicole Longo  |    March 26, 2018
Earlier this year, we examined research that shows Part B spending continues to be a small, stable share of overall Medicare spending. Today, we’re looking at the trends in Average Sales Price...   Read More

Guess what? Part B drug spending remains stable share of Medicare spending

By Nicole Longo  |    January 23, 2018
Did you know that if you look at medicines in the pipeline for previously unmet medical needs, many are new and exciting immunotherapy treatments that are physician administered? That means these...   Read More

Medicare Monday: CMS withdraws Part B demo, takes positive step forward on CMMI

By Nicole Longo  |    October 30, 2017
In case you missed it, earlier this month, the Center for Medicare & Medicaid Services formally withdrew a controversial proposal that would have had a detrimental impact on patient access to...   Read More

Medicare Monday: Medicare turns 52!

By Nicole Longo  |    July 31, 2017
This weekend (July 30) marked 52 years since Medicare was signed into law by President Lyndon B. Johnson as a part of the Social Security Act Amendments. To celebrate the occasion, we are taking a...   Read More

Medicare Monday: How Part B has evolved over the years

By Nicole Longo  |    July 24, 2017
With Medicare’s birthday rapidly approaching (July 30!), today we’re highlighting a few of the ways reimbursement for physician-administered medicines under Part B has changed since it was first...   Read More

Medicare Monday: It is Medicare’s birthday month!

By Nicole Longo  |    July 3, 2017
On July 30, 1965, Medicare was signed into law by President Lyndon B. Johnson, so this week we’re kicking off Medicare’s birthday month with a look back at some of our favorite resources.   Read More

Medicare Monday: New report highlights progress in fighting cancer with new physician-administered medicines

By Nicole Longo  |    June 12, 2017
We’ve seen significant progress in recent years in the treatment of cancer, and that progress is expected to continue. A new report released this month found that there are more than 240 new...   Read More

Medicare Monday: Catch up on MedPAC and its Part B recommendations

By Nicole Longo  |    May 29, 2017
A long weekend is the perfect time to catch up on your reading list. For policy wonks, you can get up to speed with our Memorial Day reading list on the Medicare Payment Advisory Commission...   Read More

Medicare Monday: Did you know Medicare Part B uses a market-based system to pay for medicines?

By Nicole Longo  |    May 22, 2017
We often discuss the creation of Part D when we talk about the market-based changes that the Medicare Modernization Act (MMA) made to Medicare, but that’s just one example. Today, let’s take a...   Read More

Medicare Monday: Stakeholders raise concern with MedPAC’s proposed changes to drug purchasing program

By Nicole Longo  |    April 24, 2017
A couple weeks ago, we looked at what a broad group of stakeholders have said about the recommended changes to Part B that the Medicare Payment Advisory Commission (MedPAC) voted in support of....   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates